{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:28:49Z","timestamp":1707524929717},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,20]]},"DOI":"10.7759\/cureus.35229","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T19:00:26Z","timestamp":1676919626000},"source":"Crossref","is-referenced-by-count":0,"title":["Mucopolysaccharidosis Type VI with Recurrent Chest Infection"],"prefix":"10.7759","author":[{"given":"Ashraf","family":"Numan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anoud N","family":"Alruwaili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rehab","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamasat","family":"Alsharari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mishal","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nouf N","family":"Alazmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed  A","family":"Alsaati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/2326409817718849","article-title":"Impact of enzyme replacement therapy in a patient younger than 2 years diagnosed with Maroteaux-Lamy syndrome (MPS VI)","volume":"5","author":"Guio JA","year":"2017","unstructured":"Guio JA, Ospina GA. Impact of enzyme replacement therapy in a patient younger than 2 years diagnosed with Maroteaux-Lamy syndrome (MPS VI). J Inborn Errors Metab Screen. 2017, 5:10.1177\/2326409817718849","journal-title":"J Inborn Errors Metab Screen"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4236\/crcm.2022.118047","article-title":"A child presenting with mucopolysaccharidosis","volume":"11","author":"Madi N","year":"2022","unstructured":"Madi N, Moosa FY, Thandrayen K. A child presenting with mucopolysaccharidosis. Case Rep Clin Med. 2022, 11:337-53. 10.4236\/crcm.2022.118047","journal-title":"Case Rep Clin Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3617","article-title":"Diagnosis of mucopolysaccharidosis based on history and clinical features: evidence from the Bajio region of Mexico","volume":"10","author":"Colmenares-Bonilla D","year":"2018","unstructured":"Colmenares-Bonilla D, Colin-Gonzalez C, Gonzalez-Segoviano A, Esquivel Garcia E, Vela-Huerta MM, Lopez-Gomez FG. Diagnosis of mucopolysaccharidosis based on history and clinical features: evidence from the Bajio region of Mexico. Cureus. 2018, 10:e3617. 10.7759\/cureus.3617","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11020273","article-title":"Epidemiology of mucopolysaccharidoses update","volume":"11","author":"\u00c7elik B","year":"2021","unstructured":"\u00c7elik B, Tomatsu SC, Tomatsu S, Khan SA. Epidemiology of mucopolysaccharidoses update. Diagnostics (Basel). 2021, 11:10.3390\/diagnostics11020273","journal-title":"Diagnostics (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1973.02110190597003","article-title":"Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome). I. sulfatase B deficiency in tissues","volume":"126","author":"Stumpf DA","year":"1973","unstructured":"Stumpf DA, Austin JH, Crocker AC, LaFrance M. Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome). I. sulfatase B deficiency in tissues. Am J Dis Child. 1973, 126:747-55. 10.1001\/archpedi.1973.02110190597003","journal-title":"Am J Dis Child"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1074-9","article-title":"Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance","volume":"14","author":"Akyol MU","year":"2019","unstructured":"Akyol MU, Alden TD, Amartino H, et al.. Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance. Orphanet J Rare Dis. 2019, 14:137. 10.1186\/s13023-019-1074-9","journal-title":"Orphanet J Rare Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-5","article-title":"Mucopolysaccharidosis VI","volume":"5","author":"Valayannopoulos V","year":"2010","unstructured":"Valayannopoulos V, Nicely H, Harmatz P, Turbeville S. Mucopolysaccharidosis VI. Orphanet J Rare Dis. 2010, 5:5. 10.1186\/1750-1172-5-5","journal-title":"Orphanet J Rare Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066804","article-title":"Illness perception and clinical treatment experiences in patients with M. Maroteaux-Lamy (mucopolysaccharidosis type VI) and a Turkish migration background in Germany","volume":"8","author":"Dilger H","year":"2013","unstructured":"Dilger H, Leissner L, Bosanska L, Lampe C, Pl\u00f6ckinger U. Illness perception and clinical treatment experiences in patients with M. Maroteaux-Lamy (mucopolysaccharidosis type VI) and a Turkish migration background in Germany. PLoS One. 2013, 8:e66804. 10.1371\/journal.pone.0066804","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413456","article-title":"Mucopolysaccharidosis type VI, an updated overview of the disease","volume":"22","author":"D'Avanzo F","year":"2021","unstructured":"D'Avanzo F, Zanetti A, De Filippis C, Tomanin R. Mucopolysaccharidosis type VI, an updated overview of the disease. Int J Mol Sci. 2021, 22:10.3390\/ijms222413456","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2741\/4490","article-title":"Mucopolysaccharidosis VI: pathophysiology, diagnosis and treatment","volume":"22","author":"Harmatz P","year":"2017","unstructured":"Harmatz P, Shediac R. Mucopolysaccharidosis VI: pathophysiology, diagnosis and treatment. Front Biosci (Landmark Ed). 2017, 22:385-406. 10.2741\/4490","journal-title":"Front Biosci (Landmark Ed)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-020-0972-y","article-title":"Mucopolysaccharidosis type VI: case report with first neonatal presentation with ascites fetalis and rapidly progressive cardiac manifestation","volume":"21","author":"Honjo RS","year":"2020","unstructured":"Honjo RS, Vaca EC, Leal GN, et al.. Mucopolysaccharidosis type VI: case report with first neonatal presentation with ascites fetalis and rapidly progressive cardiac manifestation. BMC Med Genet. 2020, 21:37. 10.1186\/s12881-020-0972-y","journal-title":"BMC Med Genet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.3420","article-title":"Home treatment of type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome) an alternative at this time of COVID-19 pandemic: A case in Peru","volume":"8","author":"Cortez Miranda JL","year":"2020","unstructured":"Cortez Miranda JL, Blacido Trujillo L, Liendo Chocano ME. Home treatment of type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome) an alternative at this time of COVID-19 pandemic: A case in Peru. Clin Case Rep. 2020, 8:3483-8. 10.1002\/ccr3.3420","journal-title":"Clin Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2015.03.005","article-title":"Identifying the need for a multidisciplinary approach for early recognition of mucopolysaccharidosis VI (MPS VI)","volume":"115","author":"Choy YS","year":"2015","unstructured":"Choy YS, Bhattacharya K, Balasubramaniam S, et al.. Identifying the need for a multidisciplinary approach for early recognition of mucopolysaccharidosis VI (MPS VI). Mol Genet Metab. 2015, 115:41-7. 10.1016\/j.ymgme.2015.03.005","journal-title":"Mol Genet Metab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/TACG.S68650","article-title":"Diagnostic and treatment strategies in mucopolysaccharidosis VI","volume":"8","author":"Vairo F","year":"2015","unstructured":"Vairo F, Federhen A, Baldo G, Riegel M, Burin M, Leistner-Segal S, Giugliani R. Diagnostic and treatment strategies in mucopolysaccharidosis VI. Appl Clin Genet. 2015, 8:245-55. 10.2147\/TACG.S68650","journal-title":"Appl Clin Genet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X20938245","article-title":"A case study of three patients with mucopolysaccharidoses in Hue Central Hospital","volume":"8","author":"Kiem Hao T","year":"2020","unstructured":"Kiem Hao T, Diem Chi NT, Hong Duc NT, Kim Hoa NT. A case study of three patients with mucopolysaccharidoses in Hue Central Hospital. SAGE Open Med Case Rep. 2020, 8:2050313X20938245. 10.1177\/2050313X20938245","journal-title":"SAGE Open Med Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-012-9555-1","article-title":"Respiratory and sleep disorders in mucopolysaccharidosis","volume":"36","author":"Berger KI","year":"2013","unstructured":"Berger KI, Fagondes SC, Giugliani R, et al.. Respiratory and sleep disorders in mucopolysaccharidosis. J Inherit Metab Dis. 2013, 36:201-10. 10.1007\/s10545-012-9555-1","journal-title":"J Inherit Metab Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.prrv.2010.10.005","article-title":"Respiratory manifestations in mucopolysaccharidoses","volume":"12","author":"Muhlebach MS","year":"2011","unstructured":"Muhlebach MS, Wooten W, Muenzer J. Respiratory manifestations in mucopolysaccharidoses. Paediatr Respir Rev. 2011, 12:133-8. 10.1016\/j.prrv.2010.10.005","journal-title":"Paediatr Respir Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/471325","article-title":"Glycosaminoglycan storage disorders: a review","volume":"2012","author":"Coutinho MF","year":"2012","unstructured":"Coutinho MF, Lacerda L, Alves S. Glycosaminoglycan storage disorders: a review. Biochem Res Int. 2012, 2012:471325. 10.1155\/2012\/471325","journal-title":"Biochem Res Int"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1203\/01.PDR.0000156510.96253.5A","article-title":"Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models","volume":"57","author":"Simonaro CM","year":"2005","unstructured":"Simonaro CM, D'Angelo M, Haskins ME, Schuchman EH. Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models. Pediatr Res. 2005, 57:701-7. 10.1203\/01.PDR.0000156510.96253.5A","journal-title":"Pediatr Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker397","article-title":"Musculoskeletal manifestations of mucopolysaccharidoses","volume":"50 Suppl 5","author":"Morishita K","year":"2011","unstructured":"Morishita K, Petty RE. Musculoskeletal manifestations of mucopolysaccharidoses. Rheumatology (Oxford). 2011, 50 Suppl 5:v19-25. 10.1093\/rheumatology\/ker397","journal-title":"Rheumatology (Oxford)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/133338-mucopolysaccharidosis-type-vi-with-recurrent-chest-infection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:53:45Z","timestamp":1707508425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/133338-mucopolysaccharidosis-type-vi-with-recurrent-chest-infection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,20]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.35229","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,20]]}}}